Glenys M. Otter

429 total citations
24 papers, 369 citations indexed

About

Glenys M. Otter is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Glenys M. Otter has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Glenys M. Otter's work include Biochemical and Molecular Research (4 papers), Cancer therapeutics and mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Glenys M. Otter is often cited by papers focused on Biochemical and Molecular Research (4 papers), Cancer therapeutics and mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Glenys M. Otter collaborates with scholars based in United States, China and Germany. Glenys M. Otter's co-authors include Franz A. Schmid, F. M. Sirotnak, Ting‐Chao Chou, Francis M. Sirotnak, Joseph I. DeGraw, James R. Piper, Wei Ren, Kyoichi A. Watanabe, Grazyna Ciszewska and Ji Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Glenys M. Otter

23 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenys M. Otter United States 11 211 111 99 46 40 24 369
Judith A. Besserer United States 8 241 1.1× 95 0.9× 122 1.2× 59 1.3× 41 1.0× 10 397
Randall W. Steinkampf United States 9 225 1.1× 82 0.7× 159 1.6× 18 0.4× 23 0.6× 13 385
Christine Williamson United Kingdom 14 210 1.0× 55 0.5× 186 1.9× 22 0.5× 37 0.9× 24 443
Thierry Louat Belgium 14 347 1.6× 114 1.0× 75 0.8× 53 1.2× 70 1.8× 22 617
Mary E. Scott United States 11 186 0.9× 197 1.8× 39 0.4× 11 0.2× 25 0.6× 13 453
Ming-Yu Chu United States 5 248 1.2× 61 0.5× 89 0.9× 69 1.5× 49 1.2× 7 352
Betsy A. Dusak United States 7 234 1.1× 244 2.2× 47 0.5× 17 0.4× 44 1.1× 11 547
Santwana Kar United States 9 136 0.6× 110 1.0× 95 1.0× 19 0.4× 11 0.3× 11 372
J. Michael Wardleworth United Kingdom 11 194 0.9× 216 1.9× 99 1.0× 15 0.3× 28 0.7× 12 421
Diana C. West United States 9 292 1.4× 98 0.9× 146 1.5× 47 1.0× 20 0.5× 10 525

Countries citing papers authored by Glenys M. Otter

Since Specialization
Citations

This map shows the geographic impact of Glenys M. Otter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenys M. Otter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenys M. Otter more than expected).

Fields of papers citing papers by Glenys M. Otter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenys M. Otter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenys M. Otter. The network helps show where Glenys M. Otter may publish in the future.

Co-authorship network of co-authors of Glenys M. Otter

This figure shows the co-authorship network connecting the top 25 collaborators of Glenys M. Otter. A scholar is included among the top collaborators of Glenys M. Otter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenys M. Otter. Glenys M. Otter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Ting‐Li, Ting‐Chao Chou, Ji Young Kim, et al.. (1995). 9-Substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 38(17). 3226–3235. 71 indexed citations
2.
Chou, Ting‐Chao, et al.. (1995). Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro. Cancer Chemotherapy and Pharmacology. 37(3). 222–228. 31 indexed citations
3.
Bunni, Marlene A., Francis M. Sirotnak, Glenys M. Otter, & David G. Priest. (1994). Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice. Cancer Chemotherapy and Pharmacology. 34(6). 455–458. 9 indexed citations
4.
Otter, Glenys M. & F. M. Sirotnak. (1994). Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine. Cancer Chemotherapy and Pharmacology. 33(4). 286–290. 8 indexed citations
5.
Sodum, Rama S., et al.. (1994). Synthesis and in vitro cytotoxicity of 6-vinyluridine and related compounds. Bioorganic & Medicinal Chemistry Letters. 4(3). 469–472. 9 indexed citations
6.
Sirotnak, F. M., Glenys M. Otter, & Franz A. Schmid. (1993). Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.. PubMed. 53(3). 587–91. 13 indexed citations
7.
Piper, James R., et al.. (1993). Studies on analogs of classical antifolates bearing the naphthoyl group in place of benzoyl in the side chain. Journal of Medicinal Chemistry. 36(26). 4161–4171. 28 indexed citations
8.
Dicker, Adam P., Mark Waltham, Matthias Volkenandt, et al.. (1993). Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.. Proceedings of the National Academy of Sciences. 90(24). 11797–11801. 31 indexed citations
9.
10.
Piper, James R., C. A. Johnson, Glenys M. Otter, & Francis M. Sirotnak. (1992). Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10-dideazaaminopterin and an alternative synthesis of 10-ethyl-10-deazaaminopterin (edatrexate). Journal of Medicinal Chemistry. 35(16). 3002–3006. 13 indexed citations
11.
Schmid, Franz A., Glenys M. Otter, & Ikuo Hirano. (1988). L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublines. Leukemia Research. 12(1). 67–70. 1 indexed citations
12.
13.
Chou, Ting‐Chao, et al.. (1988). Chemical synthesis and biological activities of 5-deazaaminopterin analogs bearing substituent(s) at the 5- and/or 7-position(s). Journal of Medicinal Chemistry. 31(6). 1209–1215. 14 indexed citations
14.
Sirotnak, F. M., Franz A. Schmid, Glenys M. Otter, James R. Piper, & Jane Montgomery. (1988). Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models.. PubMed. 48(20). 5686–91. 6 indexed citations
15.
Schmid, Franz A., Glenys M. Otter, & Chia‐Fu Chen. (1986). Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.. PubMed. 46(9). 4469–71. 2 indexed citations
16.
Otter, Glenys M., et al.. (1986). Eicosanoids and metastasis: experimental aspects in Lewis lung carcinoma.. PubMed. 9(1). 97–104. 14 indexed citations
17.
Schmid, Franz A., F. M. Sirotnak, Glenys M. Otter, & Joseph I. DeGraw. (1985). New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.. PubMed. 69(5). 551–3. 65 indexed citations
18.
Otter, Glenys M., et al.. (1985). Further evaluation of bimolane and analogs as potential antitumor agents. European Journal of Cancer and Clinical Oncology. 21(4). 493–497. 7 indexed citations
19.
Schmid, Franz A., Glenys M. Otter, & Bipin M. Mehta. (1985). Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.. PubMed. 45(1). 40–4. 4 indexed citations
20.
Schmid, Franz A., Glenys M. Otter, & Christiane Stock. (1980). Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.. PubMed. 40(3). 830–3. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith A. Besserer Breakdown of academic impact, for papers by Randall W. Steinkampf Breakdown of academic impact, for papers by Christine Williamson Breakdown of academic impact, for papers by Thierry Louat Breakdown of academic impact, for papers by Mary E. Scott Breakdown of academic impact, for papers by Ming-Yu Chu Breakdown of academic impact, for papers by Betsy A. Dusak Breakdown of academic impact, for papers by Santwana Kar Breakdown of academic impact, for papers by J. Michael Wardleworth Breakdown of academic impact, for papers by Diana C. West
Rankless by CCL
2026